Peer Reviewed
By:  Jagdeep Singh Gandhi, BSc (Hons), MBChB, MRCSEd, FRCOphth
Assessment of Risk Factor Profiles in Acute Retinovascular Occlusion

Update on Proliferative Vitreoretinopathy
By:  Marc J. Spirn, MD

IOL Fixation Techniques
By:  Gábor B. Scharioth, MD
A European surgeon offers his views on the treatment of luxated intraocular lenses

IOL Fixation Techniques
By:  Karim N. Jamal, MD; Pravin U. Dugel, MD
The case for ACIOL

Case Study
By:  Felipe P. P. De Almeida, MD; Kyle J. Alliman, MD; Harry W. Flynn, Jr., MD
Photic Maculopathy Following Exchange of Crystalens: Clinical and Spectral-domain OCT Features

The Problems With EMR
By:  Andrew E. Mathis, PhD, Medical Editor
What's holding practices back from adopting electronic medical systems? Why are predicted efficiencies not materializing?

Use and Abuse of Modifier -25
By:  Kevin J. Corcoran, C.O.E., C.P.C., F.N.A.O.
Are you using modifier -25 correctly in submitting reimbursement forms to CMS for intravitreal injection?

Fine-Tuning Your Anti-VEGF Injection Protocols
By:  Andrew E. Mathis, PhD, Medical Editor
The second article in our series recapping research and analysis presented at our annual meeting

Photo Essay
By:  Muralidharan R. Upendran, MBBS, MRCOphth; Giuliana Silvestri, MD, FRCPEd, FRCSEd, FRCOphth
Treatment of CNV Secondary to Sorsby's Macular Dystrophy With Intravitreal Ranibizumab

Re-Flow Strategy With 25-g "One Pars Plana Port" Technique: Personal Strategy for Vitreoretinal Surgery
By:  Cesare Forlini, MD; Matteo Forlini, MD; Paolo Rossini, MD

AION and Retinal Artery Occlusion After Intravitreal Injection of Ranibizumab for Diabetic Macular Edema
By:  Dimitrios Stylianos Kontadakis, MD; Ilaria Zucchiatti, MD; Maria Lucia Cascavilla, MD; Maurizio Battaglia Parodi, MD; Stefano Vergallo, MD; Alessandro Papayannis, MD; Francesco Bandello, MD
This report highlights the need to monitor patients for vascular complications of anti-VEGF therapy

Upfront
By:  Jason S. Slakter, M.D.
From the editor-in-chief

Subspecialty News
By:  Jack Persico, Executive Editor
Dr. Ambati: In the forefront of AMD research; news from the Retinal Congress; and more

Journal Club
New department

Coding Q&A
By:  Riva Lee Asbell
Medicare rulings on intravitreal injections

Focus On
By:  Leslie Goldberg, Associate Editor
Autofluorescence and disease progress

Clinical Trial Spotlight
By:  Andrew E. Mathis, PhD, Medical Editor
iSONEP targets S1P in AMD

Clinical Trials Update

Calendar